Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM) has reported earnings 22 times since Mar 30, 2021. The stock moves an average of ±2.99% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +6.7% (Aug 10, 2021) and its largest decline was -10.89% (May 15, 2024). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±2.99%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☀ PRE | $15.05 | $15.05 | $14.71 | 56,386 | -1.97% | open_in_new |
| Mar 10, 2026 | ☀ PRE | $15.74 | $16.11 | $14.91 | 991,900 | -2.61% | open_in_new |
| Nov 06, 2025 | ☀ PRE | $7.38 | $7.82 | $7.35 | 617,600 | +0.55% | open_in_new |
| Aug 07, 2025 | ☀ PRE | $7.61 | $7.80 | $7.03 | 486,600 | -10.79% | open_in_new |
| May 08, 2025 | ☀ PRE | $7.66 | $7.92 | $7.77 | 316,900 | +0.91% | open_in_new |
| Feb 27, 2025 | ☀ PRE | $8.64 | $8.87 | $8.61 | 385,100 | +1.89% | open_in_new |
| Nov 07, 2024 | ☀ PRE | $16.50 | $17.19 | $15.58 | 520,700 | -5.46% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $17.00 | $17.20 | $16.38 | 706,200 | -0.97% | open_in_new |
| May 15, 2024 | ☽ POST | $26.69 | $28.11 | $26.72 | 709,900 | -10.89% | open_in_new |
| Mar 14, 2024 | ☀ PRE | $16.79 | $17.39 | $16.91 | 384,700 | -0.41% | open_in_new |
| Nov 08, 2023 | ☀ PRE | $9.88 | $10.27 | $9.94 | 123,100 | +0.81% | open_in_new |
| Aug 10, 2023 | ☀ PRE | $10.09 | $10.65 | $10.29 | 173,000 | -0.68% | open_in_new |
| May 11, 2023 | ☽ POST | $9.63 | $9.77 | $9.62 | 182,600 | +1.46% | open_in_new |
| Mar 09, 2023 | ☀ PRE | $10.94 | $11.45 | $11.07 | 190,300 | +0.09% | open_in_new |
| Nov 14, 2022 | ☀ PRE | $12.99 | $13.30 | $12.59 | 153,400 | +2.44% | open_in_new |
| Aug 10, 2022 | ☀ PRE | $13.86 | $14.27 | $13.93 | 215,900 | -0.85% | open_in_new |
| May 16, 2022 | ☀ PRE | $10.56 | $11.80 | $10.88 | 502,800 | +2.45% | open_in_new |
| Mar 17, 2022 | ☀ PRE | $11.94 | $12.85 | $12.81 | 217,800 | +4.57% | open_in_new |
| Nov 09, 2021 | ☀ PRE | $23.92 | $23.92 | $22.50 | 313,700 | -4.46% | open_in_new |
| Aug 10, 2021 | ☀ PRE | $26.73 | $28.83 | $28.49 | 362,200 | +6.7% | open_in_new |
| May 14, 2021 | ☀ PRE | $28.35 | $29.74 | $27.66 | 179,500 | -0.32% | open_in_new |
| Mar 30, 2021 | ☀ PRE | $38.02 | $40.36 | $39.73 | 225,400 | +4.42% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±2.99%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260610 | open_in_new SEC.gov |
| 8-K | 20260608 | open_in_new SEC.gov |
| 8-K | 20260518 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
| 4 | 20260506 | open_in_new SEC.gov |
| 144 | 20260505 | open_in_new SEC.gov |
| S-3ASR | 20260428 | open_in_new SEC.gov |
| DEFA14A | 20260428 | open_in_new SEC.gov |
Frequently asked about CGEM earnings
When does Cullinan Therapeutics, Inc. report earnings next? expand_more
Cullinan Therapeutics, Inc. (CGEM)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CGEM stock move after earnings? expand_more
Over 22 reports, CGEM has moved an average of ±2.99% the session after earnings, closing higher 50.0% of the time.
What was CGEM's biggest post-earnings move? expand_more
CGEM's largest post-earnings gain on record was +6.7% on Aug 10, 2021, and its largest decline was -10.89% on May 15, 2024.
Where can I find Cullinan Therapeutics, Inc.'s SEC filings? expand_more
All of Cullinan Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right